Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2008
09/16/2008CA2298768C Stress tolerance and delayed senescence in plants
09/16/2008CA2269640C Enzymatic cofactor cycling using soluble pyridine nucleotide transhydrogenase
09/16/2008CA2239519C Specific binding members for human carcinoembryonic antigen, materials and methods
09/16/2008CA2202470C Intracellular isoform of the interleukin-1-receptor antagonist
09/16/2008CA2132091C Antibodies to alphavbeta3 integrin
09/16/2008CA2120732C Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
09/12/2008WO2008109839A1 Cardiac-specific progenitor cells
09/12/2008WO2008109832A2 Viable near-infrared fluorochrome labeled cells and methods of making and using same
09/12/2008WO2008109668A2 Methods to control cell movement in hollow fiber bioreactors
09/12/2008WO2008109659A2 Complexes of hyaluronans, other matrix components, hormones and growth factors for maintenance, expansion and/or differentiation of cells
09/12/2008WO2008109479A2 Methods for selecting cells with enhanced growth and production properties
09/12/2008WO2008109431A2 Constitutively open herg (kv11.1) mutant channels
09/12/2008WO2008109410A1 Use of copper and glutamate in cell culture for production of polypeptides
09/12/2008WO2008109063A2 Procurement, isolation and cryopreservation of endometrial/menstrual cells
09/12/2008WO2008108794A2 Controlling dendritic cell maturation state in the lymphoid tissue equivalent of an artificial immune system
09/12/2008WO2008108679A1 Tumor vaccine, a method for producing a tumor vaccine and a method for carrying out antitumor immunotherapy
09/12/2008WO2008108668A1 Transferases, epimerases, polynucleotides encoding these and uses thereof
09/12/2008WO2008108549A1 Method on long-term structural preservation of hemocyte utilizing cellular lyophilization technique
09/12/2008WO2008108466A1 Improved halohydrin epoxidase
09/12/2008WO2008108345A1 Insect-resistant protein and insect-resistance gene encoding the insect-resistant protein
09/12/2008WO2008108344A1 Cell for gene therapy of lcat deficiency, and replication-deficient retrovirus vector and plasmid for use in the production of the cell
09/12/2008WO2008108325A1 Novel beta-galactoside-alpha-2,6-sialyltransferase, gene encoding the same and method for enhancing enzymatic activity
09/12/2008WO2008108257A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
09/12/2008WO2008108116A1 Cellulase enzyme and method of producing the same
09/12/2008WO2008108006A1 Cell isolation method, cell testing method and reagent kit therefor
09/12/2008WO2008107695A1 Automated culture of stem cells
09/12/2008WO2008107522A1 Novel acidic glycan markers of human cells
09/12/2008WO2008106986A1 Pig model for psoriasis
09/12/2008WO2008106985A1 Pig model
09/12/2008WO2008106771A1 Devices and methods for production of cell aggregates
09/12/2008WO2008070235A3 Composition for preserving reproductive cells and mehod of using
09/12/2008WO2008067807A3 (r)-hydroxynitrile lyase from brassicaceae
09/12/2008WO2008051568A9 Methods and compositions for treatment of bone defects with placental cell populations
09/12/2008WO2007081631A3 Method of producing insulin-secreting cells from adult stem cells via transfection
09/12/2008WO2006091895A3 Method for the treatment of retinopathy of prematurity and related retinopathic diseases
09/12/2008WO2006038908A3 Ancestral and cot viral sequences, proteins and immunogenic compositions
09/12/2008CA2715856A1 Pig model for psoriasis
09/12/2008CA2715852A1 A pig whose genome comprises a site-specific, heterologous recombination site
09/12/2008CA2680254A1 Complexes of hyaluronans, other matrix components, hormones and growth factors for maintenance, expansion and/or differentiation of hepatic cells
09/12/2008CA2680196A1 Transferases, epimerases, polynucleotides encoding these and uses thereof
09/12/2008CA2679941A1 Use of copper and glutamate in cell culture for production of polypeptides
09/12/2008CA2679926A1 Insect-resistant protein and insect-resistance gene encoding the insect-resistant protein
09/12/2008CA2679841A1 Variant activin receptor polypeptides and uses thereof
09/12/2008CA2679834A1 Procurement, isolation and cryopreservation of endometrial/menstrual cells
09/12/2008CA2679703A1 A novel .beta.-galactoside-.alpha.2,6-sialyltransferase, a gene encoding thereof, and a method for enhancing enzyme activity
09/12/2008CA2679045A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
09/12/2008CA2679011A1 Devices and methods for production of cell aggregates
09/12/2008CA2678893A1 Methods to control cell movement in hollow fiber bioreactors
09/11/2008US20080222756 Nucleic acid constructs and methods for producing altered seed oil compositions
09/11/2008US20080222755 Method for modifying plant morphology, biochemistry and physiology
09/11/2008US20080222753 Transgenic seeds, plants; recombinant expression cassettes; host cells
09/11/2008US20080222749 Cotton variety FM 9063B2F
09/11/2008US20080222748 Hybrid seeds, plants, plant cells, plant tissue; textiles; herbicide resitance
09/11/2008US20080222747 Cotton variety FM 9060F
09/11/2008US20080222746 Seeds, plants, plant cells and part of plants, cotton lint or fiber, and cotton textile; herbicide resistance, insect resistance, bacterial disease resistance, fungal disease resistance, male sterility, modified carbohydrate metabolism and modified fatty acid metabolism
09/11/2008US20080222745 Colcemid-Treatment of Oocytes to enhance Nuclear Transfer Cloning
09/11/2008US20080222742 Plasmid comprising ribosmal protein promoter sequences for use as tool in controlling and enhancing genic expression in transgenic cells; biodrug
09/11/2008US20080222741 Expression Profile Of Prostate Cancer
09/11/2008US20080222740 Improved properties such as temperature and/or pH stability, pH activity profile, temperature activity profile, substrate profile, improved performance in animal feed in vitro or in vivo
09/11/2008US20080221309 MN Gene and Protein
09/11/2008US20080221308 HDAC9 polypeptides and polynucleotides and uses thereof
09/11/2008US20080221220 Antiinflammatory, antitumor and anticarcinogenic agents; rheumatic arthritis, psoriasis, transplant rejection, osteoporosis, Paget's disease, osteoarthritis, ankylosing spondylitis; 2',4'-dichloro-biphenyl-4-ylhydroxy or imine compounds
09/11/2008US20080221146 Inhibit the multimerization of nucleophosmin; cancer
09/11/2008US20080221057 Gene expression inhibition; drug screening; wnt genes; catenins
09/11/2008US20080221055 Compositions and methods for inhibiting expression of huntingtin gene
09/11/2008US20080221046 Macrolides With Anti-Inflammatory Activity
09/11/2008US20080221037 Methods and compositions for treating disorders involving excitotoxicity
09/11/2008US20080221030 Inhibition of Wet Type Age Related Macular Degeneration (Amd) by Adiponectin or Acrp 30
09/11/2008US20080221016 Modulating Glucocorticoid Induced TNF Receptor with an agent that binds GITR; binding a fusion protein to a GITR ligand to modulate regulatory T cell function; Multiple Sclerosis, Insulin-Dependent Diabetes Mellitus, Inflammatory Bowel Disease, Ulcerative Colitis, Crohns Disease
09/11/2008US20080221014 Method of Diagnosing and Treating Glioma
09/11/2008US20080221011 CR2-FH C-reactive protein, factor H fusion protein; inhibiting complement activation of the alternative pathway
09/11/2008US20080220526 Cell culture surface coating comprising galactomannan gum for use in propagation of preferential cells
09/11/2008US20080220525 Solid culture support comprising oxidized silicones and nanostructure coatings for use in propagating preferential cells
09/11/2008US20080220524 Three dimensional gum matrices for cell culture, manufacturing methods and methods of use
09/11/2008US20080220523 Bioreactor comprising hollow fiber membrane chambers for use in propagation of stem cells; tissue engineering; regenerative medicine
09/11/2008US20080220522 Using capillary pressure to control migration of propagating cells in matrix
09/11/2008US20080220521 Sheet for guiding regeneration of mesenchymal tissue and production method thereof
09/11/2008US20080220520 Cryopreservation of human embryonic stem cells in microwells
09/11/2008US20080220506 Device comprising biopolymer gel dispersion feed pump for preparing solid support for cell propagation
09/11/2008US20080220500 Expression vector comprising nucleotide sequences coding lipogenic enzyme for treatment and prevention of cardiovascular, inflammatory, nervous system, gastrointestinal and psychological disorders
09/11/2008US20080220498 Modified hydrolase for enhancing nutrient quality of animal feeds
09/11/2008US20080220479 Expression vector comprising nucleotide sequences coding cytokine receptor specific immunoglobulin for treatment and prevention of inflammation, cartilage degradation and bone resorption
09/11/2008US20080220475 mTOR LIGANDS AND POLYNUCLEOTIDES ENCODING mTOR LIGANDS
09/11/2008US20080220471 Nucleotide sequences coding Tet repressor (TetR) protein for use as gene targeting tool in genetic engineering
09/11/2008US20080220466 Using gradient separation to isolated endothelial progenitor cells from cultured tissues
09/11/2008US20080220456 Luminescence resonance energy transfer (lret) assays for clostridial toxin activity
09/11/2008US20080220455 p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING FOR APOPTOSIS REGULATOR
09/11/2008US20080220453 Using expression of oncogene (Bmi1) as diagnostic indicator of cell proliferative disorders
09/11/2008US20080220451 T1r2 binding assays
09/11/2008US20080220431 Cell fusion method
09/11/2008US20080220429 Single nucleotide polymorphisms and the identification of lactose intolerance
09/11/2008US20080220410 Method for replicating the hepatitis c virus
09/11/2008US20080220095 Red blood cells loaded with s-nitrosothiol and uses therefor
09/11/2008US20080220085 Culture of adipose stem cells; nervous system disorders
09/11/2008US20080220025 grafting a mixture of alloactivated lymphocytes in a compatible drug excipient, in or around a tumor site, to elicite an antitumor immunology response; cellular immunology and cancer therapy
09/11/2008US20080220019 in a cell culture, for use as antibodies or vaccines against hepatitis virus; genetic engineering
09/11/2008US20080219999 Immunoadhesin for the prevention of rhinovirus infection
09/11/2008US20080219997 Her-2 binding antagonists
09/11/2008US20080219995 Il-32 monoclonal antibodies and uses thereof
09/11/2008US20080219992 Pancreatic protein for use in identifying modulators for prevention and treatment of cell proliferative disorders